Predictors for outcome and treatment delay in patients with tuberculous meningitis

Jau Jiuan Sheu, Rey Yue Yuan, Chih Chao Yang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND: Tuberculous meningitis (TBM) is a challenge for clinicians because of the difficulty in making an early diagnosis and the severe consequences of delaying treatment. The objective of this study was to assess predictors of outcome and to evaluate factors critical to treatment delay of TBM. METHODS: One hundred and five adult patients with TBM, between 1997 and 2006, were retrospectively studied. Treatment delay was defined as progression of stage and physician delay between the initial presentation and the start of antituberculosis therapy. Factors contributing to the outcome, progression of stage, and prolonged physician delay were evaluated using univariate and multivariate analyses. RESULTS: Fifty patients (47.6%) experienced prolonged physician delay, and 38 (36.2%) had progression of stage. Thirty-four patients (32.4%) had an acute clinical course, and 76 (72.4%) received initial antibacterial therapy. Prolonged physician delay and progression of stage were important prognostic factors for poor outcome. Stage I at admission and prolonged physician delay were important factors contributing to progression of stage. An acute clinical course and an initial antibacterial therapy were important factors contributing to prolonged physician delay. CONCLUSIONS: Rapid diagnosis and early treatment before the occurrence of progression of stage are crucial for the outcome of TBM. TBM may present with an acute course, and when discrimination from bacterial meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early antituberculosis therapy when persistent fever, deteriorated consciousness status, or progression of stage occurs during antibacterial therapy.

Original languageEnglish
Pages (from-to)134-139
Number of pages6
JournalAmerican Journal of the Medical Sciences
Volume338
Issue number2
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Meningeal Tuberculosis
Physicians
Therapeutics
Bacterial Meningitides
Secondary Prevention
Consciousness
Early Diagnosis
Fever
Multivariate Analysis

Keywords

  • Outcome
  • Treatment delay
  • Tuberculous meningitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Predictors for outcome and treatment delay in patients with tuberculous meningitis. / Sheu, Jau Jiuan; Yuan, Rey Yue; Yang, Chih Chao.

In: American Journal of the Medical Sciences, Vol. 338, No. 2, 08.2009, p. 134-139.

Research output: Contribution to journalArticle

@article{f3140bae3ffe427798d0d9d0132fafbd,
title = "Predictors for outcome and treatment delay in patients with tuberculous meningitis",
abstract = "BACKGROUND: Tuberculous meningitis (TBM) is a challenge for clinicians because of the difficulty in making an early diagnosis and the severe consequences of delaying treatment. The objective of this study was to assess predictors of outcome and to evaluate factors critical to treatment delay of TBM. METHODS: One hundred and five adult patients with TBM, between 1997 and 2006, were retrospectively studied. Treatment delay was defined as progression of stage and physician delay between the initial presentation and the start of antituberculosis therapy. Factors contributing to the outcome, progression of stage, and prolonged physician delay were evaluated using univariate and multivariate analyses. RESULTS: Fifty patients (47.6{\%}) experienced prolonged physician delay, and 38 (36.2{\%}) had progression of stage. Thirty-four patients (32.4{\%}) had an acute clinical course, and 76 (72.4{\%}) received initial antibacterial therapy. Prolonged physician delay and progression of stage were important prognostic factors for poor outcome. Stage I at admission and prolonged physician delay were important factors contributing to progression of stage. An acute clinical course and an initial antibacterial therapy were important factors contributing to prolonged physician delay. CONCLUSIONS: Rapid diagnosis and early treatment before the occurrence of progression of stage are crucial for the outcome of TBM. TBM may present with an acute course, and when discrimination from bacterial meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early antituberculosis therapy when persistent fever, deteriorated consciousness status, or progression of stage occurs during antibacterial therapy.",
keywords = "Outcome, Treatment delay, Tuberculous meningitis",
author = "Sheu, {Jau Jiuan} and Yuan, {Rey Yue} and Yang, {Chih Chao}",
year = "2009",
month = "8",
doi = "10.1097/MAJ.0b013e3181a590f1",
language = "English",
volume = "338",
pages = "134--139",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Predictors for outcome and treatment delay in patients with tuberculous meningitis

AU - Sheu, Jau Jiuan

AU - Yuan, Rey Yue

AU - Yang, Chih Chao

PY - 2009/8

Y1 - 2009/8

N2 - BACKGROUND: Tuberculous meningitis (TBM) is a challenge for clinicians because of the difficulty in making an early diagnosis and the severe consequences of delaying treatment. The objective of this study was to assess predictors of outcome and to evaluate factors critical to treatment delay of TBM. METHODS: One hundred and five adult patients with TBM, between 1997 and 2006, were retrospectively studied. Treatment delay was defined as progression of stage and physician delay between the initial presentation and the start of antituberculosis therapy. Factors contributing to the outcome, progression of stage, and prolonged physician delay were evaluated using univariate and multivariate analyses. RESULTS: Fifty patients (47.6%) experienced prolonged physician delay, and 38 (36.2%) had progression of stage. Thirty-four patients (32.4%) had an acute clinical course, and 76 (72.4%) received initial antibacterial therapy. Prolonged physician delay and progression of stage were important prognostic factors for poor outcome. Stage I at admission and prolonged physician delay were important factors contributing to progression of stage. An acute clinical course and an initial antibacterial therapy were important factors contributing to prolonged physician delay. CONCLUSIONS: Rapid diagnosis and early treatment before the occurrence of progression of stage are crucial for the outcome of TBM. TBM may present with an acute course, and when discrimination from bacterial meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early antituberculosis therapy when persistent fever, deteriorated consciousness status, or progression of stage occurs during antibacterial therapy.

AB - BACKGROUND: Tuberculous meningitis (TBM) is a challenge for clinicians because of the difficulty in making an early diagnosis and the severe consequences of delaying treatment. The objective of this study was to assess predictors of outcome and to evaluate factors critical to treatment delay of TBM. METHODS: One hundred and five adult patients with TBM, between 1997 and 2006, were retrospectively studied. Treatment delay was defined as progression of stage and physician delay between the initial presentation and the start of antituberculosis therapy. Factors contributing to the outcome, progression of stage, and prolonged physician delay were evaluated using univariate and multivariate analyses. RESULTS: Fifty patients (47.6%) experienced prolonged physician delay, and 38 (36.2%) had progression of stage. Thirty-four patients (32.4%) had an acute clinical course, and 76 (72.4%) received initial antibacterial therapy. Prolonged physician delay and progression of stage were important prognostic factors for poor outcome. Stage I at admission and prolonged physician delay were important factors contributing to progression of stage. An acute clinical course and an initial antibacterial therapy were important factors contributing to prolonged physician delay. CONCLUSIONS: Rapid diagnosis and early treatment before the occurrence of progression of stage are crucial for the outcome of TBM. TBM may present with an acute course, and when discrimination from bacterial meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early antituberculosis therapy when persistent fever, deteriorated consciousness status, or progression of stage occurs during antibacterial therapy.

KW - Outcome

KW - Treatment delay

KW - Tuberculous meningitis

UR - http://www.scopus.com/inward/record.url?scp=69349105559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69349105559&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e3181a590f1

DO - 10.1097/MAJ.0b013e3181a590f1

M3 - Article

C2 - 19680017

AN - SCOPUS:69349105559

VL - 338

SP - 134

EP - 139

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 2

ER -